Beta-blocker associated with better outcomes in treatment of infantile vascular tumors

Compared with oral corticosteroids, use of the beta-blocker propranolol for treatment of infantile hemangiomas (IHs) was associated with higher rates of lesion clearance, fewer adverse effects, fewer surgical interventions after treatment, and lowers cost, according to a report published Online First by Archives of Dermatology.

A common type of vascular tumor, IH tends to grow rapidly during the first three to 12 months of age, and then slowly and spontaneously regress from three to seven years of age, according to background information in the study. However, this regression may not completely improve the patient's appearance. Further, when IH is untreated, patients may experience ulceration, scarring, recurrent bleeding and impairment of vision, hearing, feeding and defecation. In complicated cases, patients may have , structural abnormalities, cosmetic disfigurement or psychosocial problems. "Therefore, IHs often require systemic, surgical and/or to avoid these ," write the authors. In most cases, corticosteroids are used to treat the disorder, with oral prednisolone the most common choice. Since 2008, studies have suggested that propranolol (a beta blocker drug used for heart and circulatory problems) may also help treat IH.

Cynthia J. Price, M.D., formerly of the Miller School of Medicine, University of Miami, and colleagues sought to evaluate the use of propranolol in patients with IH but with no , and to gather information about optimal length of treatment, associated adverse effects and relapses when treatment ends. Between February 2005 and October 2010, they conducted a multicenter, retrospective review of the medical charts of 110 patients with IHs. Researchers used photographs and clinical examination results to divide patients into two groups: those whose IH was cleared by 75 percent or more (defined as a reduction of at least 75 percent in the tumor's volume) and those whose tumor clearance was less than 75 percent.

On average, treatment with propranolol lasted for 7.9 months and treatment with lasted 5.2 months. Of the 68 patients who received propranolol, 56 (82 percent) had tumor clearance of 75 percent or more, compared with 12 (29 percent) of 42 patients who received oral corticosteroids. Adverse events occurred in three patients receiving propranolol and all 42 patients receiving corticosteroids. In patients who received propranolol, relapse occurred after treatment ended, but improvement was noticed after another round of treatment. Eight patients (12 percent) in the propranolol group and 12 patients (29 percent) in the corticosteroid group needed further surgery. Overall, the average per-patient costs of treatment were $205.32 and $416.00 in the propranolol and oral prednisolone groups, respectively.

"In conclusion, our study showed that propranolol therapy was more effective in lesion clearance, required fewer surgical referrals after treatment and demonstrated superior tolerance, with minimal adverse effects," write the authors. "Propranolol proved to be safe in treating IH in our patients as no major adverse effects occurred. Also, therapy was more cost-effective, with a cost reduction of more than 50 percent per patient."

More information: Arch Dermatol. Published online August 15, 2011. doi:10.1001/archdermatol.2011.203

add to favorites email to friend print save as pdf

Related Stories

Hope for treatment of cocaine addiction

Nov 17, 2010

(PhysOrg.com) -- Two separate discoveries by researchers at the University of Wisconsin-Milwaukee (UWM) offer potential for development of a first-ever pharmacological treatment for cocaine addiction.

Recommended for you

Is Australia prepared for Ebola?

50 minutes ago

Australia needs to be proactive about potential disease outbreaks like Ebola and establish a national centre for disease control.

Dallas hospital confirms first Ebola case in US

6 hours ago

A patient at a Dallas hospital has tested positive for Ebola, the first case of the disease to be diagnosed in the United States, federal health officials announced Tuesday.

First case of Ebola diagnosed in US

7 hours ago

The United States has diagnosed its first case of the deadly Ebola virus in a man who became infected in Liberia and traveled to Texas, US health officials said Tuesday.

Study finds acupuncture does not improve chronic knee pain

8 hours ago

Among patients older than 50 years with moderate to severe chronic knee pain, neither laser nor needle acupuncture provided greater benefit on pain or function compared to sham laser acupuncture, according to a study in the ...

User comments